The last one given at the 12 week mark also assessed acceptability and ease of use as well as willingness of the patients to continue trial treatment on a long term basis. Throughout the trial, one patient from the placebo control group did not follow up and three patients withdrew; one from the control group kept forgetting and two from the garlic group experienced gastrointestinal discomfort. Tolerability was generally high, a quarter of the garlic group and 8% of the control group reported reflux and taste sensations which were easily subsided by splitting dosage to two times a day or taking the capsules with food. Majority (65%) of the sample preferred to take all capsules at the same time and 92% of the garlic group were willing to continue taking the capsules as long as they helped with blood pressure in comparison to 66% of the control